Micrographia Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 8

Micrographia Bio General Information

Description

Developer of a drug discovery platform designed to accelerate biomedical innovation. The company's platform focuses on the autonomous assessment of the therapeutic mechanism of action as well as combining novel methods for multiplexed microscopy imaging with machine-intelligent computer vision software and eradicates the commercial barrier to developing new medicines via artificial intelligence-enabled bioimage analysis to understand the true nature of the therapeutic activity, enabling healthcare professionals to resolve the true molecular functions of potential therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Translation & Innovation Hub
  • 84 Wood Lane
  • London W12 0BZ
  • England, United Kingdom
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Translation & Innovation Hub
  • 84 Wood Lane
  • London W12 0BZ
  • England, United Kingdom

Micrographia Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Micrographia Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Micrographia Bio‘s full profile, request access.

Request a free trial

Micrographia Bio Patents

Micrographia Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4573211-A1 Method and kits Pending 18-Aug-2022
GB-202212055-D0 Method and kits Inactive 18-Aug-2022
US-20250320541-A1 Method and kits Pending 18-Aug-2022
WO-2024038203-A1 Method and kits Inactive 18-Aug-2022
EP-4314776-A1 Imaging system and method of operation Pending 01-Apr-2021 G01N21/6458
To view Micrographia Bio’s complete patent history, request access »

Micrographia Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Micrographia Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Micrographia Bio‘s full profile, request access.

Request a free trial

Micrographia Bio FAQs

  • When was Micrographia Bio founded?

    Micrographia Bio was founded in 2019.

  • Where is Micrographia Bio headquartered?

    Micrographia Bio is headquartered in London, United Kingdom.

  • What is the size of Micrographia Bio?

    Micrographia Bio has 19 total employees.

  • What industry is Micrographia Bio in?

    Micrographia Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Micrographia Bio a private or public company?

    Micrographia Bio is a Private company.

  • What is Micrographia Bio’s current revenue?

    The current revenue for Micrographia Bio is .

  • How much funding has Micrographia Bio raised over time?

    Micrographia Bio has raised $8.01M.

  • Who are Micrographia Bio’s investors?

    Samos Investments, , Apsara Investments, , and DCVC are 5 of 15 investors who have invested in Micrographia Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process